Concepedia

Thomas Sears

TS

5

Publications

121

Citations

5

H-Index

2019

Active since

Affiliations

University of California, Davis(Current)

Neurological Surgery

Northwestern University

Thomas Sears is an author at University of California, Davis specializing in medicine, pharmacology, and molecular pharmacology.

ORCID

Top concepts

Publications per year

2019–2023

5

Publications

5

Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors

Michael Drumm, Wenxia Wang, Thomas Sears et al. · Journal of Clinical Investigation · 2023 · 45 citations · Full text

Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells

Sandipan Datta, Thomas Sears, Gino Cortopassi et al. · Biomedicine & Pharmacotherapy · 2020 · 33 citations · Full text

IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat

Thomas Sears, Craig Horbinski, Kevin Woolard · Journal of Neuro-Oncology · 2021 · 17 citations · Full text

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts

Matthew McCord, Elizabeth T. Bartom, Kirsten B. Burdett et al. · Cancers · 2022 · 15 citations · Full text

Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer

Sonia Allen, Sandipan Datta, José Armando Pancorbo Sandoval et al. · Mitochondrion · 2019 · 11 citations

, , +8

Rows per page

1–5 of 5